Get the latest Harrow, Inc. (HROW) stock news and headlines to help you in your trading and investing decisions.

In a study comparing diclofenac to dexamethasone in 40 pediatric patients undergoing strabismus surgery, diclofenac was superior in each of five postoperative outcome parameters measured: patient ...

The following are safe ophthalmic preparations: Ciloxan® ophthalmic ointment and solution (cipro-floxacin), Vigamox® ophthalmic solution (moxifloxacin), Ocuflox® ophthalmic solution (ofloxacin ...

The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis.

SNS Insider Reveals Strategic Outlook for the U.S. Uveitis Treatment Market—Valued at USD 0.71 Billion in 2023—With the Nation Poised to Maintain North American Dominance Amid Rising Adoption ...

The African Pharmaceutical Market is projected to grow at an impressive CAGR of 6-8% by 2029, driven by a booming population, ...

SNS Insider Reveals Strategic Outlook for the U.S. Uveitis Treatment Market—Valued at USD 0.71 Billion in 2023—With the Nation Poised to Maintain North American Dominance Amid Rising Adoption of ...

SNS Insider Reveals Strategic Outlook for the U.S. Uveitis Treatment Market-Valued at USD 0.71 Billion in 2023-With the Nation Poised to Maintain Nor ...

How Much Does an Ophthalmic Medical Technician Make? Ophthalmic Medical Technicians made a median salary of $41,780 in 2023. The best-paid 25% made $49,740 that year, while the lowest-paid 25% ...

ForSight Robotics secures $125M Series B funding, led by Eclipse, to tackle global vision crisis and perform robotic cataract surgery clinical trials.